Jamming fat metabolism stops blood cancer cells

Targeted cancer therapies work by blocking specific, cancer-driving mutations. But in a new laboratory study, researchers show that cancers driven by several different mutations can all be stopped by...

Targeting uniquely dangerous postpartum breast cancers

Breast cancers that emerge within five to ten years of pregnancy are more likely to become life-threatening. A new study finds that these postpartum breast tumors represent a unique subtype of cancer...

Clinical trial elevates new target for fighting cancers

Researchers have verified a much-needed new target for treating cancers that often become resistant to existing therapies and become deadly. In an early-phase clinical trial, the researchers tested...

Valuable recognition for OHSU’s molecular pathology fellowship

OHSU’s Molecular Genetic Pathology Fellowship has received a grant from NeoGenomics Laboratories that will support fellows for the 2021-22 and 2022-23 academic years in the Knight Cancer...

How to make more cancers vulnerable to immunotherapies

Cancer immunotherapies called checkpoint inhibitors can bring dramatic, life-saving results – but only for a limited fraction of patients. Aiming to help more patients benefit, researchers in...

Overcoming drug resistance to stop a deadly blood cancer

Cancer researchers have discovered a potential way to make targeted therapy drugs more effective and longer lasting for people with acute myeloid leukemia, or AML. The scientists showed how it is...

Discovery sheds light on early-onset colorectal cancer

The rapid rise of colorectal cancer in younger people remains perplexing, but a new study fills in a missing piece of the puzzle. Researchers found that three genes involved in immunity and...

Innovation expands view into workings of single cells

Researchers have devised a way to multiply by more than ten-fold the accessible details of gene activity in individual cells. It’s a big leap in the effort to understand cancer development, brain...